Is TB-500 Legal in Ohio? Federal Law, State Rules, and How to Get It
HealthRX.com
TB-500 has no legal compounding pathway in Ohio yet
See the public record for TB-500
At a glance
- FDA approval / No approved drug contains TB-500 [1]
- Compounding bulks list / Not listed; in none of the three nomination categories [2][3][4]
- Safety-risk page / In the 'nominated but withdrawn' table, not the active category 2 table [8]
- Advisory committee / July 23, 2026 vote favored listing; advice only [9][6]
- Pending HHS draft / Non-binding; TB-500 acetate by injection [6][7]
- Sport / WADA prohibits thymosin-beta4 and derivatives at all times [10][11]
What TB-500 is
TB-500 is a synthetic 7-amino-acid fragment (residues 17 to 23, N-acetylated) of the 43-amino-acid protein thymosin beta-4. It is not full-length thymosin beta-4 [1]. FDA found no article in which TB-500 was given to a human [1]. It is sold online as a 'research use only' injectable powder, and FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].
What the federal position is
A bulk substance used by a state-licensed pharmacy or physician must meet an applicable USP or National Formulary monograph, be a component of an FDA-approved drug, or appear on FDA's compounding bulks list [4]. FDA's July 2026 review found no monograph for TB-500 and no FDA-approved drug containing it [1]. TB-500 appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians, and it is also absent from FDA's separate list for outsourcing facilities [2][3][4]. FDA's safety-risk page lists it in the table of substances nominated but withdrawn, which previously held it in the safety-risk category. That removal was not a finding that it is safe [8].
Questions worth asking
What Ohio law says
Ohio's controlled-substance chapter defines a controlled substance as a drug, compound, mixture, preparation or substance included in schedule I, II, III, IV or V [5]. The federal compounding conditions above are the ones that apply to state-licensed pharmacies and physicians that compound drugs [4].
What people on Reddit report
Pharmacy owners and clinic patients in one peptide thread discussing whether this compound and similar peptides can be compounded now, and how state boards treat it.
As a pharmacy owner of a 503a, there are some peptides legal to compound now. The majority, such as all the ones being reviewed by the committee are currently on the do not compound list.Read the source discussion
Speaking to my state board, they said providers can prescribe any peptide therapy they want as off label use, but the pharmacies are not allowed to compound them. There is also a lot of variability on each state boards interpretations or willingness to enforce peptide compounding.Read the source discussion
The advisory vote and the pending HHS draft
On July 23, 2026, FDA's Pharmacy Compounding Advisory Committee voted in favor of adding TB-500 to the compounding bulks list, against FDA staff's recommendation [9][6]. Staff had proposed that neither the free base nor the acetate be added, citing no evidence of effectiveness for wound healing, no human data of any kind, and immunogenicity risk from injection [1]. The vote is advice only. Adding TB-500 to the list takes formal rulemaking [9][6][4].
HHS filed a draft enforcement-discretion policy on October 28, 2026, with publication scheduled for October 30, 2026 [6][7]. It names TB-500 among six peptides and covers TB-500 acetate by subcutaneous or intramuscular injection. HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it if the policy's conditions are met [6][7]. The notice says it is not binding on HHS or the public [6].
Sport and safety
WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in section S2.3, growth factors and growth factor modulators. It is prohibited at all times, in and out of competition, on the 2026 List, and it stays on the 2027 List [10][11].
FDA's adverse-event database search through March 26, 2025 retrieved no TB-500 reports. Its food and supplement complaint system retrieved two cases about a blended TB-500 and BPC-157 product, with no safety assessment [1]. FDA found no published case reports, safety in humans is unknown, and its stated concern for injection is immunogenicity [1]. There is no approved dose and no human dosing study of TB-500 [1].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Frequently asked questions
Is TB-500 legal in Ohio?
Did the FDA advisory committee make TB-500 legal to compound?
Can a pharmacy compound TB-500 for an Ohio patient?
Is TB-500 banned in sport?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
Are peptides now legal in the US?
Peptides as a group are not established as legal in the US. TB-500 is not FDA-approved and is not on FDA's compounding bulks list, so it has no approved or listed pathway in the US. A draft HHS policy names six peptides, including TB-500, but it is non-binding and is not an approval.
Will TB-500 show on a drug test?
It is not established whether TB-500 shows on a drug test. What is documented is that WADA names thymosin-beta4 and its derivatives, including TB-500, as prohibited at all times, in and out of competition, on the 2026 List, and that it stays on the 2027 List.
References
Show all 12 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Chapter 3719 - Ohio Revised Code | Ohio Laws.
- Official web page.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- World Anti-Doping Agency.
- Reddit participants. The FDA committee just voted yes on BPC, TB-500, and 4 others. (r/NTNPerformance). Accessed 2026-11-11.